Mydimed

MydimedMydimed
M

Mydimed

Predicts and prevents adverse drug reactions to reduce hospitalizations.

Website
2016Inactive8
Rate
Advertise here

About

Mydimed developed an AI-powered platform called the ADR Predictor, designed to identify patients at high risk for adverse drug reactions. By flagging these individuals, the system aims to enable proactive interventions, thereby preventing or shortening hospital stays.

Technology stack

detected 2026-06-26
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Mydimed do?

Mydimed developed an AI-powered platform called the ADR Predictor, designed to identify patients at high risk for adverse drug reactions. By flagging these individuals, the system aims to enable proactive interventions, thereby preventing or shortening hospital stays.

How much funding has Mydimed raised?

Mydimed has raised a total of $100K in funding. The most recent round on record is Seed.

When was Mydimed founded?

Mydimed was founded in 2016.

What industry does Mydimed operate in?

Mydimed operates in Healthcare, Disease Management, HealthTech, MedTech, Clinical Trials, Drug Discovery.

How many employees does Mydimed have?

Mydimed has approximately 8 people on record.

What is Mydimed's current status?

Mydimed's current operating status is: Inactive.

What is Mydimed's revenue?

StartupHub estimates Mydimed's annual revenue at $2.3M (range $1.4M to $4.0M, 63% confidence), based on comparable companies in the sector.

What is Mydimed's valuation?

StartupHub estimates Mydimed's effective valuation at $346K (range $250K to $600K, 10% confidence), based on comparable companies in the sector.